Petrovax has received a patent for the original medicine product Longidaza®, which is valid in South Korea protecting.
During the COVID-19 pandemic, the drug product...
Longidaza®, developed in Russia, received a patent in India. This was reported by the company "Petrovax". Thus, Longidasa, which already has patents in a...
Russian pharmaceutical company Petrovax is expanding its export portfolio and considering new markets for its pharmaceuticals and vaccines. At CPHI Worldwide 2021, an international...
Petrovax Pharm LLC has received a European patent for the original medicine product Longidaza®, which is valid in the UK, Germany, France, Switzerland, Ireland,...